PACTR2008060000852767
Double dose Kaletra in children
Doubling The Dose Of Lopinavir/Ritonavir As An Approach To Using Kaletra® In TB/HIV-infected Patients Receiving Rifampicin-based TB Treatment
University of Cape Town; University of Cape Town·Not Applicable·Pan Africa Clinical Trials Registry·drugTerminated
Study focus
- Disease/Condition
- Infections and Infestations; Infections and Infestations
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- University of Cape Town; University of Cape Town
- Funder
- European and Developing Countries Clinical Trials Partnership ; European and Developing Countries Clinical Trials Partnership ; South African Department of Health; South African Department of Health
- Location
- South Africa
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Jan 01, 1900
- End date
- Jan 01, 1900
Summary
Comparing Lopinavir concentrations in HIV-infected children with or without TB
ICD-10 classifications
Certain infectious and parasitic diseasesInfestation, unspecifiedOther specified infestationsOther infestationsSequelae of infectious and parasitic diseases
Data source
- Registry
- Pan Africa Clinical Trials Registry
- Trial ID
- PACTR2008060000852767
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for PACTR2008060000852767 through Pure Global AI's free database. This Not Applicable trial is sponsored by University of Cape Town; University of Cape Town and is currently Terminated. The study focuses on Infections and Infestations; Infections and Infestations.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.